Alantra named as ‘European Corporate Finance House of the Year 2019′

Alantra, the global mid-market investment banking and asset management specialist, has won the European Corporate Finance House of the Year Award at The Private Equity Awards 2019, hosted by Real Deals.

The Private Equity Awards, now in its eighteenth year, recognise the overall achievements of firms advising on European transactions. The criteria for winning the award includes success in creating value for clients through outstanding deal execution and the provision of genuine market and sector insight, as well as the overall evolution of the firm and its strategy.

“We are very pleased to have received this accolade for our achievements in the last 12 months. 2018 was a very strong year for Alantra in terms of activity, quality of deals advised, and overall growth”, Santiago Eguidazu, Executive Chairman of Alantra said. “The award is a testament to Alantra’s position as one of the best Mid-Market advisors in Europe”.

In 2018, Alantra advised on 202 transactions (+8.6% vs. 2017), of which 97 were in M&A (total value of over €10 Bn), 55 were in portfolio advisory (total volume of over €38 Bn), 22 in debt advisory (over €2 Bn of new debt raised), 18 in capital markets (over €1 Bn raised) and 10 in strategic advisory. This performance merited the Firm to rank amongst the top five independent advisors in Europe by number of deals, according to Mergermarket.

Notable deals included leading the sale of Sun European Partners’ portfolio company ELIX Polymers to Chinese corporate Sinochem International; advising Synova Capital on the refinance and subsequent sale of 4Ways Healthcare to ECI Partners; and managing the investment by Charterhouse Capital Partners into SLR Consulting, providing an exit for 3i and other minority shareholders.

< Go back to results
 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare. 

Alantra strengthens its pharma sector focus with senior appointment

Alantra has appointed Anthony Harrington as a partner and key member of its healthcare advisory team. A leading advisor to the pharma services sector, Anthony has over 15 years of M&A experience in the healthcare sector.  

Alantra advises Maine Pointe on its partnership with SGS

Alantra advises US-based Maine Pointe on its international investment by SGS, the Swiss-listed, global testing, inspection and certification specialist. 

Alantra advises ECI on its investment in Send For Help

Alantra has advised ECI on its investment in Send For Help, the global leading provider of lone worker protection.